Elizabeth A Spencer

12PUBLICATIONS
34CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Behavioural epidemiologyAutoimmunityInfant and child healthAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 22, 2026
Subcutaneous infliximab in pediatric inflammatory bowel disease: Sustained remission, predictable pharmacokinetics, and real-world US implementation.

|May 14, 2026
Prevalence, age-distribution, and impact on management of acne in patients on upadacitinib for inflammatory bowel disease: insights from a single-center survey.

|Jun 30, 2025
Evaluation and Management of Glucocorticoid-Induced Adrenal Insufficiency in IBD: An Expert Opinion.

Cindy C Y Law, Rachel Sheskier, Natalia Viera-Feliciano

|Feb 08, 2025
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study.

Shlomi Cohen, Elizabeth A Spencer, Michael T Dolinger

|Jan 15, 2025
Effectiveness and Safety of Adalimumab in Patients With Very Early-Onset Inflammatory Bowel Disease: A Retrospective Study on Behalf of the Porto Inflammatory Bowel Disease Working Group of European Society for Pediatric Gastroenterology Hepatology and Nutrition.

Yael Weintraub, Lauren V Collen, Seamus Hussey

|Jul 22, 2024
Risankizumab Is Effective for The Management of Crohn's Disease of the Pouch.

Maia Kayal, Elizabeth A Spencer, Matthew Smyth

Pageof 2

Frequent Collaborators

3 joint publications

Michael T Dolinger

2 joint publications

Marla C Dubinsky

2 joint publications

Dror S Shouval

2 joint publications

Kaija-Leena Kolho